ZIM - Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga
Shares of Science Applications International Corporation (NASDAQ:SAIC) declined 11% to $119.91 following first-quarter results.
SAIC reported a 9% revenue decline year over year in the fiscal first quarter of 2025 to $1.847 billion, marginally beating the analyst consensus estimate of $1.844 billion. Adjusted EPS of $1.92 was in line with the analyst consensus estimate, according to data from Benzinga Pro.
SAIC shares dipped 11% to $119.91 on Monday.
Here are some other stocks moving in today’s mid-day session.
Gainers
- Microbot Medical Inc. (NASDAQ:MBOT) jumped 92.5% to $1.9301 after the company received FDA approval to proceed with its pivotal human clinical trial.
- Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares jumped 75% to $3.62. Bio-Path presented interim results from Phase 2 study of Prexigebersen (BP1001) in combination with decitabine and venetoclax for acute myeloid leukemia at the American Society Of Clinical Oncology Annual Meeting.
- GameStop Corp. (NYSE:GME) shares climbed 34.5% to $31.13 after Roaring Kitty on a Reddit post, shared his position on the stock.
- Professional Diversity Network, Inc. (NASDAQ:IPDN) gained 28.5% to $0.65. Professional Diversity Network recently named Megan Bozzuto as interim CFO.
- MarineMax, Inc. (NYSE:HZO) gained 27% to $36.16. OneWater Marine Inc. is reportedly said to be in advanced discussions to acquire MarineMax.
- Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 27% to $0.1271 after dipping 12% on Friday.
- MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) climbed 26.5% to $0.4425 after the company reported an agreement to acquire Oxylus Global.
- Dogness (International) Corporation (NASDAQ:DOGZ) gained 23.5% to $13.65
- Affimed N.V. (NASDAQ:AFMD) gained 22.2% to $5.25 as the company issued follow-up data of AFM24 plus atezolizumab showing durable responses in heavily pretreated NSCLC EGFR wild-type patients and positive initial data from the NSCLC EGFR mutant cohort.
- Concord Medical Services Holdings Limited (NYSE:CCM) rose 17.6% to $0.5883.
- MacroGenics, Inc. (NASDAQ:MGNX) rose 17.5% to $4.8001.
- Personalis, Inc. (NASDAQ:PSNL) gained 17.5% to $1.5282.
- Liquidia Corporation (NASDAQ: